惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

美团技术团队
博客园_首页
量子位
F
Fortinet All Blogs
L
LangChain Blog
The Cloudflare Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
大猫的无限游戏
大猫的无限游戏
H
Hackread – Cybersecurity News, Data Breaches, AI and More
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
V
Visual Studio Blog
Blog — PlanetScale
Blog — PlanetScale
博客园 - 叶小钗
Apple Machine Learning Research
Apple Machine Learning Research
博客园 - Franky
G
Google Developers Blog
阮一峰的网络日志
阮一峰的网络日志
T
Tailwind CSS Blog
WordPress大学
WordPress大学
宝玉的分享
宝玉的分享
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
有赞技术团队
有赞技术团队
U
Unit 42
IT之家
IT之家

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness
CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Po...
Bruce Japsen · 2026-05-14 · via Forbes - Healthcare
Traders At The NYSE As S&P Futures Rise As EU-US Deal Eases Trade Fears

In this photo is CVS Health Corp. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Monday, July 28, 2025. Photographer: Michael Nagle/Bloomberg

© 2025 Bloomberg Finance LP

A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.

CVS said the sale to GenieRx followed a “comprehensive sale process” that was approved by the U.S. Bankruptcy Court for the Northern District of Texas. GenieRx, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Healthcare Services, “will have the opportunity to strengthen” Omnicare’s service, CVS said.

For CVS, the deal is the latest to focus on profitable businesses. The company’s Aetna health insurance unit left the business of selling individual coverage under the Affordable Care Act known as Obamacare and the company has scaled back opening senior health clinics in favor or smaller drugstore formats.

"We are entering this next phase with clarity on what matters most: delivering reliable pharmacy services, maintaining safe and clinically appropriate care, and being transparent and fair in how we operate,” said Omnicare’s president, David Azzolina, in a statement. “Our teams continue to show a deep commitment to our customers, and I am grateful for the work they do every day to support residents in skilled nursing and assisted living settings.”

When CVS purchased Omnicare for more than $12 billion more than a decade ago, the drugstore giant wanted to expand in the growing business of dispensing and managing prescriptions for the booming number of Americans taking specialized drugs. But the deal never really worked out and the business had low growth and was dogged by fraud investigation that cost the company hundreds of millions of dollars.

MORE FOR YOU

The Omnicare sale is expected to close later this year, CVS said.

“GenieRx’s investment in Omnicare is a testament to the strength of their platform and their impressive employee culture and commitment to putting patients and customers first,” said Rowan Farber, CEO of Integro Healthcare Services. “We admire the trust Omnicare has earned with its customers over decades of serving skilled nursing and assisted living partners, and we look forward to working collaboratively with their team to continue building on that strong foundation and legacy. Together, we share a commitment to delivering reliable service, clinical expertise, and continuity of care to the patients and communities who depend on it most.”